Literature DB >> 19962487

Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease.

Tarun Sabharwal1, Cedric Manlhiot, Susanne M Benseler, Pascal N Tyrrell, Nita Chahal, Rae S M Yeung, Brian W McCrindle.   

Abstract

We sought to determine whether differences exist in the factors associated with transient coronary artery (CA) dilation only compared to CA aneurysms after Kawasaki disease (KD). We reviewed all patients with KD assessed and treated at a single tertiary institution from January 1990 to April 2007. Of 1,374 patients (63% men) with KD, 1,108 (81%) had no CA abnormalities; 180 (13%) had CA dilation only, and 86 (6%) had CA aneurysms. The factors associated with any CA abnormality included male gender (odds ratio [OR] 1.8, p <0.001), lower albumin (OR per 1 g/dl, 1.07; p < 0.001), lower hemoglobin (OR per 10 g/dl; 1.02, p = 0.008), diagnosed outside of the 1 to 9-year-age range (OR for <1 year old, 1.5; p = 0.04; OR for >9 years old, 1.9, p = 0.03), longer duration of fever before treatment (OR per day, 1.05, p = 0.002), greater platelet count (OR per 10 x 10(9)/L, 1.14, p = 0.008), and nonresponse to initial intravenous immunoglobulin treatment (OR 2.4, p <0.001). Only age at diagnosis, duration of fever before treatment, greater platelet count, and nonresponse to initial intravenous immunoglobulin discriminated between CA dilation only versus CA aneurysms (c-statistic, 0.80, p <0.001). In conclusion, CA dilation only and CA aneurysms differ only in the total duration of inflammation, as measured by the number of days from fever onset to defervescence.

Entities:  

Mesh:

Year:  2009        PMID: 19962487     DOI: 10.1016/j.amjcard.2009.07.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

2.  Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.

Authors:  Sunil J Ghelani; Craig Sable; Bernhard L Wiedermann; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

3.  Response to "Acute kidney injury occurs only rarely in patients with Kawasaki disease".

Authors:  Gwo-Tsann Chuang; Luan-Yin Chang
Journal:  Pediatr Res       Date:  2017-09-20       Impact factor: 3.756

4.  Complete and incomplete Kawasaki disease: two sides of the same coin.

Authors:  Cedric Manlhiot; Erin Christie; Brian W McCrindle; Hans Rosenberg; Nita Chahal; Rae S M Yeung
Journal:  Eur J Pediatr       Date:  2011-12-03       Impact factor: 3.183

5.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

6.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

7.  Proteomics study of serum exosomes in Kawasaki disease patients with coronary artery aneurysms.

Authors:  Xiao-Fei Xie; Hong-Juan Chu; Yu-Fen Xu; Liang Hua; Zhou-Ping Wang; Ping Huang; Hong-Ling Jia; Li Zhang
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

8.  Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Authors:  Georgia Giannouli; Chryssa Tzoumaka-Bakoula; Ioannis Kopsidas; Paraskevi Papadogeorgou; George P Chrousos; Athanasios Michos
Journal:  Pediatr Cardiol       Date:  2013-03-06       Impact factor: 1.655

9.  Kawasaki disease: a review with emphasis on cardiovascular complications.

Authors:  Ricardo Duarte; Silvia Cisneros; Gabriel Fernandez; Daniel Castellon; Cesar Cattani; Cíntia A Melo; Asier Apocada
Journal:  Insights Imaging       Date:  2010-07-30

10.  Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre.

Authors:  Alok Sunil Patel; Margaret Bruce; Whitney Harrington; Michael A Portman
Journal:  Open Heart       Date:  2015-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.